Clinical Trial Update: Targeting the Gut Microbiome to Investigate the Pathways of Progression From Obesity to Metabolic Diseases in an At-risk Population. [NA]

View source ↗

Summary

A completed University of Copenhagen clinical study investigates how the gut microbiome may influence progression from obesity to metabolic diseases in an at‑ri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance
• Obesity

Snippet

Sponsor: University of Copenhagen | Conditions: Obesity, Insulin Resistance | NA | Status: COMPLETED